Israeli FemTech Startup Patents Candida Treatment In South Africa

Israeli femtech startup Zero Candida has patented its innovative treatment for candida yeast infection with the authorities in South Africa.  

Candida is a yeast fungus that occurs naturally in the body, but an excess of it can cause infection most commonly in the mouth or vagina. It affects three out of four women worldwide at some stage in their lives, and untreated, it can cause serious health issues.  

Zero Candida’s unique treatment uses high-energy blue light to destroy the fungus quickly and without side effects, and is administered via a tampon-like medical device. 

“This first Intellectual Property marks a great potential to the company as we expect to announce additional ones in the coming future. In addition, we will be able to start commercial sales in South Africa following the US Food and Drug Administration (FDA) approval,” said Zero Candida founder and CEO Eli Ben Haroosh. 

“Zero Candida has a potential to become a technological leader and use its ground-breaking technology to expand boundaries of non-chemical candida treatment,” he said.  

“The invention of Zero Candida brings amazing news to FemTech women’s care and can become a leader in women’s health globally,” said Zero Candida Director Dr. Asher Holzer. 

“Until now, the common treatments for candida included antifungal drugs that alleviated the symptoms but failed to solve the problem at its root.”